These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. In vitro neurotoxicity of salsolinol is attenuated by the presynaptic protein α-synuclein. do Carmo-Gonçalves P; Coelho-Cerqueira E; Cortines JR; de Souza TLF; Romão L; Follmer C Biochim Biophys Acta Gen Subj; 2018 Dec; 1862(12):2835-2845. PubMed ID: 30251672 [TBL] [Abstract][Full Text] [Related]
44. The chaperone activity of α-synuclein: Utilizing deletion mutants to map its interaction with target proteins. Rekas A; Ahn KJ; Kim J; Carver JA Proteins; 2012 May; 80(5):1316-25. PubMed ID: 22274962 [TBL] [Abstract][Full Text] [Related]
45. Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation. Binolfi A; Lamberto GR; Duran R; Quintanar L; Bertoncini CW; Souza JM; Cerveñansky C; Zweckstetter M; Griesinger C; Fernández CO J Am Chem Soc; 2008 Sep; 130(35):11801-12. PubMed ID: 18693689 [TBL] [Abstract][Full Text] [Related]
46. Differences in the binding of copper(I) to α- and β-synuclein. De Ricco R; Valensin D; Dell'Acqua S; Casella L; Gaggelli E; Valensin G; Bubacco L; Mangani S Inorg Chem; 2015 Jan; 54(1):265-72. PubMed ID: 25495902 [TBL] [Abstract][Full Text] [Related]
47. Heparin and Methionine Oxidation Promote the Formation of Apolipoprotein A-I Amyloid Comprising α-Helical and β-Sheet Structures. Townsend D; Hughes E; Hussain R; Siligardi G; Baldock S; Madine J; Middleton DA Biochemistry; 2017 Mar; 56(11):1632-1644. PubMed ID: 27992182 [TBL] [Abstract][Full Text] [Related]
48. Oxidation and nitration of α-synuclein and their implications in neurodegenerative diseases. Chavarría C; Souza JM Arch Biochem Biophys; 2013 May; 533(1-2):25-32. PubMed ID: 23454347 [TBL] [Abstract][Full Text] [Related]
49. Isomers of human alpha-synuclein stabilized by disulfide bonds exhibit distinct structural and aggregative properties. Jiang C; Chang JY Biochemistry; 2007 Jan; 46(2):602-9. PubMed ID: 17209570 [TBL] [Abstract][Full Text] [Related]
50. Secondary structure of alpha-synuclein oligomers: characterization by raman and atomic force microscopy. Apetri MM; Maiti NC; Zagorski MG; Carey PR; Anderson VE J Mol Biol; 2006 Jan; 355(1):63-71. PubMed ID: 16303137 [TBL] [Abstract][Full Text] [Related]
51. Dopamine promotes alpha-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway. Cappai R; Leck SL; Tew DJ; Williamson NA; Smith DP; Galatis D; Sharples RA; Curtain CC; Ali FE; Cherny RA; Culvenor JG; Bottomley SP; Masters CL; Barnham KJ; Hill AF FASEB J; 2005 Aug; 19(10):1377-9. PubMed ID: 15946991 [TBL] [Abstract][Full Text] [Related]
52. Oxidation of methionine residues in the prion protein by hydrogen peroxide. Requena JR; Dimitrova MN; Legname G; Teijeira S; Prusiner SB; Levine RL Arch Biochem Biophys; 2004 Dec; 432(2):188-95. PubMed ID: 15542057 [TBL] [Abstract][Full Text] [Related]
53. Parkinson's disease and alpha synuclein: is Parkinson's disease a prion-like disorder? Olanow CW; Brundin P Mov Disord; 2013 Jan; 28(1):31-40. PubMed ID: 23390095 [TBL] [Abstract][Full Text] [Related]
54. Complexation of amyloid fibrils with charged conjugated polymers. Ghosh D; Dutta P; Chakraborty C; Singh PK; Anoop A; Jha NN; Jacob RS; Mondal M; Mankar S; Das S; Malik S; Maji SK Langmuir; 2014 Apr; 30(13):3775-86. PubMed ID: 24678792 [TBL] [Abstract][Full Text] [Related]
55. Diverse metastable structures formed by small oligomers of α-synuclein probed by force spectroscopy. Neupane K; Solanki A; Sosova I; Belov M; Woodside MT PLoS One; 2014; 9(1):e86495. PubMed ID: 24475132 [TBL] [Abstract][Full Text] [Related]
56. Phosphorylation does not prompt, nor prevent, the formation of alpha-synuclein toxic species in a rat model of Parkinson's disease. Azeredo da Silveira S; Schneider BL; Cifuentes-Diaz C; Sage D; Abbas-Terki T; Iwatsubo T; Unser M; Aebischer P Hum Mol Genet; 2009 Mar; 18(5):872-87. PubMed ID: 19074459 [TBL] [Abstract][Full Text] [Related]
57. Exploring the Transition of Human α-Synuclein from Native to the Fibrillar State: Insights into the Pathogenesis of Parkinson's Disease. Fazili NA; Naeem A J Fluoresc; 2016 Sep; 26(5):1659-69. PubMed ID: 27365127 [TBL] [Abstract][Full Text] [Related]
58. Modification of C Terminus Provides New Insights into the Mechanism of α-Synuclein Aggregation. Afitska K; Fucikova A; Shvadchak VV; Yushchenko DA Biophys J; 2017 Nov; 113(10):2182-2191. PubMed ID: 28939194 [TBL] [Abstract][Full Text] [Related]
59. Wildtype and A30P mutant alpha-synuclein form different fibril structures. Nielsen SB; Macchi F; Raccosta S; Langkilde AE; Giehm L; Kyrsting A; Svane AS; Manno M; Christiansen G; Nielsen NC; Oddershede L; Vestergaard B; Otzen DE PLoS One; 2013; 8(7):e67713. PubMed ID: 23861789 [TBL] [Abstract][Full Text] [Related]
60. The modification of alpha-synuclein by dicarbonyl compounds inhibits its fibril-forming process. Lee D; Park CW; Paik SR; Choi KY Biochim Biophys Acta; 2009 Mar; 1794(3):421-30. PubMed ID: 19103312 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]